Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Nationwide Children's Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Endeavor Biomedicines, Inc.
Emory University
Milton S. Hershey Medical Center
H. Lee Moffitt Cancer Center and Research Institute
Medical University of Vienna
Children's Oncology Group
St. Jude Children's Research Hospital
Pediatric Brain Tumor Consortium
St. Jude Children's Research Hospital
Augusta University
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
European Organisation for Research and Treatment of Cancer - EORTC
University of Zurich
National Institutes of Health Clinical Center (CC)
Cedars-Sinai Medical Center
University of Florida
Pfizer
National Cancer Institute (NCI)
Beijing Sanbo Brain Hospital
Milton S. Hershey Medical Center
University of Virginia
Celgene
Memorial Sloan Kettering Cancer Center
Eastern Cooperative Oncology Group
University of Iowa
Children's Oncology Group
University of Colorado, Denver
Cairo University
University of Iowa
Wake Forest University Health Sciences
National Cancer Institute (NCI)
University of Iowa
Ann & Robert H Lurie Children's Hospital of Chicago
Nicklaus Children's Hospital f/k/a Miami Children's Hospital
Washington University School of Medicine
Children's Hospital of Philadelphia
Central Hospital, Nancy, France